Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Consumer,Liraglutide,"PCOS, weight loss due to insulin resistance",Liraglutide (Saxenda),Recommended for decline,,Alimentary Tract and Metabolism
